海外の治験の状況「1」での検索結果
11240件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- MT10109L in the Treatment of Lateral Canthal Lines
- Lateral Canthal Lines
- United States
- 2018-12-20
Recruiting
- Pembrolizumab (MK-3475) as First-line Therapy for Advanced Merkel Cell Carcinoma (MK-3475-913)
- Merkel Cell Carcinoma
- Canada, France, Italy, New Zealand, Spain, Sweden
- 2018-12-19
Recruiting
- Efficacy and Safety of Axicabtagene Ciloleucel as First-Line Therapy in Participants With High-Risk Large B-Cell Lymphoma
- B-cell Lymphoma
- United States
- 2018-11-29
Recruiting
- Calcitriol Monotherapy for X-Linked Hypophosphatemia
- X-linked Hypophosphatemia;Hypophosphatemic Rickets;Hypophosphatemic Rickets, X-Linked Dominant
- United States
- 2018-11-19
Recruiting
- Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Glabellar Lines
- Glabellar Frown Lines
- United States
- 2018-11-07
Authorised
- Pembrolizumab (MK-3475) as First-Line Therapy for Advanced Merkel Cell Carcinoma
- Unresectable Stage III and Stage IV Merkel Cell Carcinoma (MCC) MedDRA version: 20.0 Level: LLT Classification code 10064025 Term: Merkel cell carcinoma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Canada, France, Italy, New Zealand, Spain, Sweden, United States
- 2018-10-24
Authorised
- First-line chemotherapy plus pembrolizumab and olaparib for BRCA non-mutated advanced EOC
- Advanced epithelial ovarian cancer MedDRA version: 20.0 Level: PT Classification code 10033128 Term: Ovarian cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Belgium, Brazil, Canada, Chile, Colombia, Czech Republic, France, Germany, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, New Zealand, Poland, Russian Federation, South Africa, Spain, Taiwan, Turkey, Ukraine, United Kingdom, United States
- 2018-10-23
Not recruiting
- ET-01 in Subjects With Lateral Canthal Lines, LCL-207
- Lateral Canthal Lines;Crow's Feet
- United States
- 2018-08-30
Recruiting
- Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy
- Chronic Graft-versus-host-disease
- United States
- 2018-08-13
Not recruiting
- Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC
- Pancreatic Ductal Adenocarcinoma;Pancreatic Cancer;Pancreatic Neoplasms
- United States
- 2018-07-23
Recruiting
- Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal Lines
- Lateral Canthal Lines
- United States
- 2019-03-27
Recruiting
- Does Preoperative Calcium and Calcitriol Decrease Rates of Post Thyroidectomy Hypocalcemia?
- Hypocalcemia;Thyroid Diseases
- United States
- 2019-03-06
Recruiting
- ET-01 in Subjects With Lateral Canthal Lines, LCL-208
- Lateral Canthal Lines;Crow's Feet
- United States
- 2019-02-08
Recruiting
- Fibroblast Specific Inhibition of LOXL2 and TGFbeta1 Signaling in Patients With Pulmonary Fibrosis.
- Idiopathic Pulmonary Fibrosis
- United States
- 2019-04-18
Not recruiting
- ET-01 in Subjects With Lateral Canthal Lines, LCL-209
- Lateral Canthal Lines;Crow's Feet
- United States
- 2019-04-10
Not recruiting
- Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines
- Glabellar Frown Lines
- United States
- 2019-05-21
Recruiting
- Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study III (BLESS III)
- Glabellar Frown Lines
- United States
- 2019-06-12
Recruiting
- AGN-151586 Dose-Ranging Study for Treatment of Glabellar Lines
- Glabellar Lines
- United States
- 2019-09-04
Recruiting
- Risk Factors for Thrombosis in Children With Central Venous Lines
- Pediatric Venous Thromboembolism
- United States
- 2019-10-03
Not recruiting
- RADIESSE Injection in Perioral and Marionette Lines
- Skin Quality
- Canada
- 2019-11-20
